Table 4. Costs of PET/CT and procedures avoided, analysis for all patients and with predictive criteria applied.
| Clinical procedures | All patients | Patients with either bilobar involvement or AFP ≥400 ng/mL | |||
|---|---|---|---|---|---|
| Cost of PET/CT for 152 patients | Cost of procedure avoided | Cost of PET/CT for 74 patients |
Cost of procedure avoided | ||
| PET/CT | $2,280,000 | – | $1,065,000 | – | |
| Hepatectomy and hospital stay | – | $712,320 | – | $474,880 | |
| TACE and hospital stay | – | $1,169,280 | – | $1,121,400 | |
| Ablation and hospital stay | – | $82,760 | – | $82,760 | |
| Net cost | $2,280,000 | $1,964,360 | $1,110,000 | $1,679,040 | |
PET, positron emission tomography; CT, computed tomography; AFP, alpha-fetoprotein; TACE, transarterial chemoembolization.